Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. - Wikidata - awgldk - TriplyDB

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

http://www.wikidata.org/entity/Q31417222

about

Management of HBV Infection in Liver Transplantation Patients Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)Prophylactic managements of hepatitis B viral infection in liver transplantation Management of chronic hepatitis B before and after liver transplantation Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease.Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation.Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.Hepatocellular carcinoma: current approaches to diagnosis and management.Hepatitis B: progress in the last 15 years.Prevention of recurrent hepatitis B post-liver transplantation.Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.Liver transplantation for viral hepatitis.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues Review article: hepatitis B and liver transplantation.Prevention of hepatitis B virus recurrence after liver transplantation.Prophylaxis of hepatitis B infection in solid organ transplant recipients.Living donor liver transplantation for hepatitis B cirrhosis.Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Liver Transplantation: East versus West.Management of the liver transplant patient.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Hepatitis B and C in liver transplantation: new strategies to combat the enemies.Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Recent advances in prevention of hepatitis B recurrence after liver transplantation.Management of hepatitis B virus infection after liver transplantation.Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.

P2860

Q24529103-62B1CA32-DA3D-45A7-8DAE-52470A328252 Q26740319-6596F0AA-876E-4B6D-9282-EE79D8969EA4 Q26772340-77339353-BDB3-4CE3-A31A-06B0EA87DF3B Q27024831-369F7229-72EA-42FA-87F7-66ED4EA71743 Q30431207-4CABB970-2EB0-4D3F-BD1D-031E55089AD4 Q33207885-4DEE27A9-BF4B-46EA-A5D1-73FD338F8CA3 Q33624284-BF3667C0-79E7-4F22-9B65-A40148DAE3B8 Q34012806-FB2B4A15-5CF2-46BF-9734-39660B3EC44F Q34171703-13FF97E7-5AD5-4E4A-AAFD-4A47E50E61C7 Q34442045-8D38D682-7776-441D-8F9E-E1D7DAF5EFC6 Q34499694-9054D282-0DD9-4203-9BE1-A9E9D3E3B4C6 Q34773704-684E91F7-1B66-4837-9C29-76E0F38A7119 Q34936238-AC408570-4286-41DC-B39C-286006AEA603 Q34936261-A975779E-71EE-4C8C-986E-8CDC3274D069 Q35076630-4F31959D-2F6A-490B-B037-C17647A77A61 Q36027124-FD28EC2B-9DF7-43B1-B508-6A8FBFDB095D Q36028324-1454C628-22F9-45A0-B67C-C39BDF21978F Q36442537-D618006C-F4F9-4817-B38B-2504E8189384 Q36447557-9CC42C8C-CBA1-4989-8833-58A3F26DBFAA Q36652077-B0DF59B1-933B-4567-A578-96EC992F67A5 Q36886518-E73DB103-6650-4480-9DA9-5E55E49E0EBE Q37010424-959E20D5-4315-4BA1-8816-7A94DB9A3F4D Q37432104-4D16E1CC-47C2-4E3B-A562-5637D259AFB2 Q37495757-31D94BAC-2E93-4A85-A21B-C831DA58F5AE Q37613378-78E5DF65-1EA8-4909-A5D8-B72A718E9AF1 Q37636100-4A609F7E-59C2-4871-93CF-9FE5D26AD7CC Q37764964-BF99DB61-992D-4B74-9309-A7134E859FE3 Q37870833-D20FCECF-830E-4C5B-BD8C-785E91143AD4 Q37886893-679FC45E-6D64-4574-8457-0E15A88C44EE Q37982346-AC60CC88-ABAD-433A-B9F6-1B5D4EF4AA12 Q38006958-C0168736-8A74-4F97-8131-BA4B84373478 Q38058545-987A314D-3D96-4336-A7E9-7741679DB088 Q38067343-2EA6488B-E472-404C-98FC-751727D7AA69 Q38088688-CEA41419-83F7-426C-8E8D-327F99AEDB14 Q38121508-69ECFB7A-00F6-45C9-A0F0-F9C4B3283542 Q38137238-94A0A7DB-0183-425B-925B-8877AAC900E6 Q38218762-49CDE2E8-3D92-4B42-8986-AB40BDD717AA Q38333875-9AD19E1F-6EA6-43F9-974B-DD2BC82E6734 Q38635614-EDFB557B-34D1-4D45-9A3D-DB8570FE9617 Q38966352-2CA38A2E-E579-4552-B07D-90CDEDE5A28D

P2860

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

http://www.wikidata.org/entity/Q31417222

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@ast

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@en

type

label

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@ast

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@en

prefLabel

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@ast

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@en

P1433

Q31417222-15A3D380-2D27-4FE6-8940-9508E1DF6BCC

P1476

Q31417222-EA4F4134-3DB5-445D-ACEA-E5F48680DDCB

P2093

Q31417222-37444156-DAE0-43CE-905B-3016D2B50750

Q31417222-524AFF90-551C-4F29-935E-1B7717EBBF6F

Q31417222-5DDE43C2-1A4C-451E-9CC2-661B4412D22F

Q31417222-A8EA79C9-AC6D-4B38-B883-96D553D9F91A

Q31417222-C696BE19-85BB-4B53-BC49-9B9DFEE87647

P304

Q31417222-5E85FA8E-1520-4104-B955-3F349141E09F

P31

Q31417222-718E534F-53E9-4C02-8C20-4875828E9BB9

P356

Q31417222-65ECA870-21CF-4BF4-BA26-6A55B15271F7

P433

Q31417222-D63D8213-7775-4B61-B5AB-9F02A2A43C52

P478

Q31417222-6694C2D9-E82A-40AF-B6C8-41DA9C7B6CCA

P577

Q31417222-2C624FD4-467B-42F7-B225-82646ACD34B7

P5875

Q31417222-F6382D4A-DC87-4884-A7E3-796863A1384B

P698

Q31417222-3E59A42C-29DD-4171-9619-D19B3B47613D

P356

P1433

Liver Transplantation

P1476

Combination low-dose hepatitis ...... sttransplantation hepatitis B.

@en

P2093

D H Crawford

http://www.w3.org/2001/XMLSchema#string

E J Gane

http://www.w3.org/2001/XMLSchema#string

G W McCaughan

http://www.w3.org/2001/XMLSchema#string

H Harley

http://www.w3.org/2001/XMLSchema#string

P W Angus

http://www.w3.org/2001/XMLSchema#string

P304

429-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JLTS.2000.8310

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227893992

http://www.w3.org/2001/XMLSchema#string

P698

10915163

http://www.w3.org/2001/XMLSchema#string